Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Radiopharm Theranostics Limited American Depositary Shares, Common Stock

RADX

NAQ

$4.83

+$0.01

(0.21%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$11.22B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

43.58K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.85

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$3.55 L

$50.82 H

$4.83

About Radiopharm Theranostics Limited American Depositary Shares, Common Stock

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcinoma patients. The company also develops RAD 302, an avß6-integrin targeting agent for the treatment of multiple cancer types; RAD 101 and RAD 102 for brain metastases; RAD 402 to treat advanced prostate cancer; and RV01 for multiple solid tumors. It has strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. more

Returns

Data is not properly formatted.

Time Frame	RADX		S&P500
1-Week Return	-6.94%%	%	2.46%%
1-Month Return	14.73%%	%	1.9%%
3-Month Return	-72.67%%	%	4.96%%

Financials

	Jun '22	Jun '23	Jun '24
Total Revenue	8.83K	292.36K	299.23K	[{"date":"2022-06-30","value":2.95,"profit":true},{"date":"2023-06-30","value":97.7,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Cost of Revenue	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Profit	8.83K	292.36K	299.23K	[{"date":"2022-06-30","value":2.95,"profit":true},{"date":"2023-06-30","value":97.7,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Gross Margin	100.00%	100.00%	100.00%	[{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Operating Expenses	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Operating Income	(19.92M)	(34.51M)	(36.62M)	[{"date":"2022-06-30","value":-1991635200,"profit":false},{"date":"2023-06-30","value":-3450808500,"profit":false},{"date":"2024-06-30","value":-3662085200,"profit":false}]
Total Non-Operating Income/Expense	(10.38M)	(65.10K)	(11.23M)	[{"date":"2022-06-30","value":-1037823000,"profit":false},{"date":"2023-06-30","value":-6510400,"profit":false},{"date":"2024-06-30","value":-1123190300,"profit":false}]
Pre-Tax Income	(30.29M)	(34.57M)	(47.85M)	[{"date":"2022-06-30","value":-3029458200,"profit":false},{"date":"2023-06-30","value":-3457318900,"profit":false},{"date":"2024-06-30","value":-4785275500,"profit":false}]
Income Taxes	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Income From Continuous Operations	(30.34M)	(34.61M)	(47.95M)	[{"date":"2022-06-30","value":-3033897900,"profit":false},{"date":"2023-06-30","value":-3461119400,"profit":false},{"date":"2024-06-30","value":-4794911900,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income	(30.34M)	(34.61M)	(47.95M)	[{"date":"2022-06-30","value":-3033897900,"profit":false},{"date":"2023-06-30","value":-3461119400,"profit":false},{"date":"2024-06-30","value":-4794911900,"profit":false}]

EPS (Diluted)	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

	Jun '22	Jun '23	Jun '24
Total Revenue	-	3210.60%	2.35%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":0.07,"profit":true}]
Cost of Revenue	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Profit	-	3210.60%	2.35%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":0.07,"profit":true}]
Gross Margin	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Operating Expenses	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Operating Income	-	73.27%	6.12%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":8.36,"profit":true}]
Total Non-Operating Income/Expense	-	(99.37%)	17152.25%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-0.58,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Pre-Tax Income	-	14.12%	38.41%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":36.77,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Income Taxes	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Income From Continuous Operations	-	14.08%	38.54%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":36.54,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income	-	14.08%	38.54%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":36.54,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Jun '22	Jun '23	Jun '24
Total Assets
Current Assets	27.26M	16.30M	22.85M	[{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":59.79,"profit":true},{"date":"2024-06-30","value":83.8,"profit":true}]
Non-current Assets	56.12M	58.65M	49.19M	[{"date":"2022-06-30","value":95.68,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":83.87,"profit":true}]
Total Assets	83.38M	74.95M	72.04M	[{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":89.89,"profit":true},{"date":"2024-06-30","value":86.39,"profit":true}]

Total Liabilities
Current Liabilities	7.88M	13.23M	17.58M	[{"date":"2022-06-30","value":44.83,"profit":true},{"date":"2023-06-30","value":75.27,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Liabilities	12.54M	16.14M	27.11M	[{"date":"2022-06-30","value":46.26,"profit":true},{"date":"2023-06-30","value":59.55,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	20.42M	29.37M	44.68M	[{"date":"2022-06-30","value":45.7,"profit":true},{"date":"2023-06-30","value":65.73,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	(30.82M)	(65.35M)	(111.34M)	[{"date":"2022-06-30","value":-3082416900,"profit":false},{"date":"2023-06-30","value":-6535386400,"profit":false},{"date":"2024-06-30","value":-11133877000,"profit":false}]
Other Stockholders' Equity	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	62.96M	44.38M	28.12M	[{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":70.49,"profit":true},{"date":"2024-06-30","value":44.67,"profit":true}]

Total Liabilities & Shareholders Equity	83.38M	73.75M	72.81M	[{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":88.45,"profit":true},{"date":"2024-06-30","value":87.32,"profit":true}]

	Jun '22	Jun '23	Jun '24
Total Assets
Current Assets	-	(40.21%)	40.17%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-100.11,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	-	4.51%	(16.13%)	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-357.44,"profit":false}]
Total Assets	-	(10.11%)	(3.89%)	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2024-06-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	67.91%	32.86%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":48.38,"profit":true}]
Non-current Liabilities	-	28.72%	67.94%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":42.27,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	-	43.84%	52.14%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":84.09,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	-	112.02%	70.36%	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":62.81,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	(29.51%)	(36.64%)	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2024-06-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(11.55%)	(1.29%)	[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2024-06-30","value":null,"profit":false}]

	Jun '23	Jun '24
Total Assets
Current Assets	16.30M	22.85M	[{"date":"2023-06-30","value":71.34,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	58.65M	49.19M	[{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":83.87,"profit":true}]
Total Assets	74.95M	72.04M	[{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":96.11,"profit":true}]

Total Liabilities
Current Liabilities	13.23M	17.58M	[{"date":"2023-06-30","value":75.27,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Liabilities	16.14M	27.11M	[{"date":"2023-06-30","value":59.55,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	29.37M	44.68M	[{"date":"2023-06-30","value":65.73,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	(65.35M)	(111.34M)	[{"date":"2023-06-30","value":-6535386400,"profit":false},{"date":"2024-06-30","value":-11133877000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	44.38M	28.12M	[{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":63.36,"profit":true}]

Total Liabilities & Shareholders Equity	73.75M	72.81M	[{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":98.71,"profit":true}]

	Jun '23	Jun '24
Total Assets
Current Assets	-	40.17%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	-	(16.13%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false}]
Total Assets	-	(3.89%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	32.86%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Liabilities	-	67.94%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	-	52.14%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	-	70.36%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	(36.64%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(1.29%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false}]

	Jun '21	Jun '22	Jun '23	Jun '24
Operating Activities
Net Operating Cash Flow	-	-	-	-	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	65.11M	9.22M	29.88M	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":14.16,"profit":true},{"date":"2024-06-30","value":45.89,"profit":true}]

Net Change in Cash	-	26.82M	(15.51M)	6.90M	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":-57.84,"profit":false},{"date":"2024-06-30","value":25.73,"profit":true}]

Free Cash Flow
Free Cash Flow	-	-	-	-	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

	Jun '21	Jun '22	Jun '23	Jun '24
Operating Activities
Net Operating Cash Flow	-	-	-	-	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	(85.84%)	224.12%	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-38.3,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]

Net Change in Cash	-	-	(157.84%)	(144.48%)	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2024-06-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	-	-	-	[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	RADX
Current Ratio	1.30

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	RADX
ROA (LTM)	-30.04%
ROE (LTM)	-131.49%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	RADX
Debt Ratio Lower is generally better. Negative is bad.	0.62
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.39

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	RADX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Radiopharm Theranostics Limited American Depositary Shares share price today?

Radiopharm Theranostics Limited American Depositary Shares (RADX) share price today is $4.83

Can Indians buy Radiopharm Theranostics Limited American Depositary Shares shares?

Yes, Indians can buy shares of Radiopharm Theranostics Limited American Depositary Shares (RADX) on Vested. To buy Radiopharm Theranostics Limited American Depositary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RADX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Radiopharm Theranostics Limited American Depositary Shares be purchased?

Yes, you can purchase fractional shares of Radiopharm Theranostics Limited American Depositary Shares (RADX) via the Vested app. You can start investing in Radiopharm Theranostics Limited American Depositary Shares (RADX) with a minimum investment of $1.

How to invest in Radiopharm Theranostics Limited American Depositary Shares shares from India?

You can invest in shares of Radiopharm Theranostics Limited American Depositary Shares (RADX) via Vested in three simple steps:

Click on Sign Up or Invest in RADX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Radiopharm Theranostics Limited American Depositary Shares shares

What is Radiopharm Theranostics Limited American Depositary Shares 52-week high and low stock price?

The 52-week high price of Radiopharm Theranostics Limited American Depositary Shares (RADX) is $50.82. The 52-week low price of Radiopharm Theranostics Limited American Depositary Shares (RADX) is $3.55.

What is Radiopharm Theranostics Limited American Depositary Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Radiopharm Theranostics Limited American Depositary Shares (RADX) is

What is Radiopharm Theranostics Limited American Depositary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Radiopharm Theranostics Limited American Depositary Shares (RADX) is 0.00

What is Radiopharm Theranostics Limited American Depositary Shares dividend yield?

The dividend yield of Radiopharm Theranostics Limited American Depositary Shares (RADX) is 0.00%

What is the Market Cap of Radiopharm Theranostics Limited American Depositary Shares?

The market capitalization of Radiopharm Theranostics Limited American Depositary Shares (RADX) is $11.22B

What is Radiopharm Theranostics Limited American Depositary Shares’s stock symbol?

The stock symbol (or ticker) of Radiopharm Theranostics Limited American Depositary Shares is RADX

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Radiopharm Theranostics Limited American Depositary Shares, Common Stock

RADX

NAQ

$4.83

+$0.01

(0.21%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Radiopharm Theranostics Limited American Depositary Shares, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²